ZA201408703B - A method of weight reduction - Google Patents

A method of weight reduction

Info

Publication number
ZA201408703B
ZA201408703B ZA2014/08703A ZA201408703A ZA201408703B ZA 201408703 B ZA201408703 B ZA 201408703B ZA 2014/08703 A ZA2014/08703 A ZA 2014/08703A ZA 201408703 A ZA201408703 A ZA 201408703A ZA 201408703 B ZA201408703 B ZA 201408703B
Authority
ZA
South Africa
Prior art keywords
weight reduction
reduction
weight
Prior art date
Application number
ZA2014/08703A
Other languages
English (en)
Inventor
Ken Walder
Guy Krippner
Geoff Nicholson
Original Assignee
Verva Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verva Pharmaceuticals Ltd filed Critical Verva Pharmaceuticals Ltd
Publication of ZA201408703B publication Critical patent/ZA201408703B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA2014/08703A 2012-05-24 2014-11-26 A method of weight reduction ZA201408703B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261651335P 2012-05-24 2012-05-24
PCT/AU2013/000259 WO2013173858A1 (en) 2012-05-24 2013-03-15 A method of weight reduction

Publications (1)

Publication Number Publication Date
ZA201408703B true ZA201408703B (en) 2018-07-25

Family

ID=49622926

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/08703A ZA201408703B (en) 2012-05-24 2014-11-26 A method of weight reduction

Country Status (16)

Country Link
US (2) US20150174108A1 (enExample)
EP (1) EP2854806A4 (enExample)
JP (1) JP6438389B2 (enExample)
KR (1) KR20150023404A (enExample)
CN (1) CN104582701B (enExample)
AU (1) AU2013202981B2 (enExample)
BR (1) BR112014029302A2 (enExample)
CA (1) CA2874512A1 (enExample)
CO (1) CO7160083A2 (enExample)
HK (1) HK1209041A1 (enExample)
MX (1) MX2014014316A (enExample)
NZ (1) NZ702666A (enExample)
RU (1) RU2664442C2 (enExample)
SG (1) SG11201407786XA (enExample)
WO (1) WO2013173858A1 (enExample)
ZA (1) ZA201408703B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2660170T3 (es) 2007-01-25 2018-03-21 NAIA Metabolic, Inc. Sensibilizadores a la insulina y métodos de tratamiento
BR112014029308A2 (pt) * 2012-05-24 2017-06-27 Verva Pharmaceuticals Ltd um método de melhorar a função hepática
US10039752B2 (en) * 2016-07-21 2018-08-07 Cipla Limited Methazolamide for the treatment of cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783241A (en) * 1957-02-26 S-acylimino-x-substituted-az-i
JP2000080047A (ja) * 1998-06-30 2000-03-21 Takeda Chem Ind Ltd 医 薬
US6946243B2 (en) * 2000-07-20 2005-09-20 Solvay Pharmaceuticals Gmbh Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
WO2002013800A2 (en) * 2000-08-11 2002-02-21 Einar Stefansson Method for the prevention and treatment of retinopathy
CA2516142A1 (en) * 2003-03-18 2004-09-30 Novartis Ag Compositions comprising fatty acids and amino acids
KR101167579B1 (ko) * 2003-04-29 2012-07-27 오렉시젠 세러퓨틱스 인크. 체중감량용 조성물
WO2005012243A2 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indole-o-glucosides
WO2007114948A2 (en) * 2006-04-04 2007-10-11 The Brigham And Women's Hospital, Inc. Methods and compositions for inhibiting cell death
ES2660170T3 (es) * 2007-01-25 2018-03-21 NAIA Metabolic, Inc. Sensibilizadores a la insulina y métodos de tratamiento
TW201105338A (en) * 2009-07-01 2011-02-16 Kissei Pharmaceutical Medicine derived from a combination of SGLT1-inhibitor and DPP-IV inhibitor
CN103068400A (zh) * 2010-06-25 2013-04-24 阿斯顿大学 具有脂类动员性质的糖蛋白及其治疗用途
JP5722892B2 (ja) * 2010-07-15 2015-05-27 武田薬品工業株式会社 複素環化合物
BR112014029308A2 (pt) * 2012-05-24 2017-06-27 Verva Pharmaceuticals Ltd um método de melhorar a função hepática

Also Published As

Publication number Publication date
AU2013202981B2 (en) 2014-11-13
CN104582701A (zh) 2015-04-29
CN104582701B (zh) 2018-01-16
BR112014029302A2 (pt) 2017-06-27
EP2854806A1 (en) 2015-04-08
HK1209041A1 (en) 2016-03-24
WO2013173858A1 (en) 2013-11-28
US20150174108A1 (en) 2015-06-25
CO7160083A2 (es) 2015-01-15
CA2874512A1 (en) 2013-11-28
JP2015520759A (ja) 2015-07-23
AU2013202981A1 (en) 2013-12-12
RU2664442C2 (ru) 2018-08-17
EP2854806A4 (en) 2015-11-18
RU2014150946A (ru) 2016-07-10
JP6438389B2 (ja) 2018-12-12
NZ702666A (en) 2016-08-26
MX2014014316A (es) 2015-07-06
US20180333398A1 (en) 2018-11-22
KR20150023404A (ko) 2015-03-05
SG11201407786XA (en) 2015-03-30

Similar Documents

Publication Publication Date Title
PL2825719T3 (pl) Sposób obsługi odwiertów
GB201223172D0 (en) Method
GB2506203B (en) Method of interacting with a simulated object
GB201212932D0 (en) Method
PL2836154T3 (pl) Sposób montażu dystalizatora
PL2817775T3 (pl) Sposób pomiaru oglądalności
GB201213636D0 (en) Method
GB201212934D0 (en) Method
GB201210858D0 (en) Method
ZA201503034B (en) Method of weight management
SG11201504454RA (en) A method of vitrification
SG11201407032WA (en) Method
PL2809816T3 (pl) Sposób ekspresji
GB201218570D0 (en) Method
SG2013017017A (en) A method of separation
GB201202198D0 (en) Method
IL235959B (en) A method for obtaining a nano-capsule structure
GB201215942D0 (en) Method of treatent
SG11201407786XA (en) A method of weight reduction
GB201223316D0 (en) Method
GB201222737D0 (en) Method
GB201214029D0 (en) method
GB201211393D0 (en) Method
GB201217688D0 (en) Method
GB201201332D0 (en) Method